Pinnacle Associates’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.6M Buy
1,570,061
+82,797
+6% +$620K 0.14% 151
2026
Q2
$10.3M Buy
1,487,264
+328,369
+28% +$1.94M 0.11% 179
2026
Q1
$4.76M Buy
1,158,895
+376,530
+48% +$1.82M 0.06% 265
2025
Q4
$5.2M Buy
782,365
+107,490
+16% +$728K 0.07% 246
2025
Q3
$4.14M Sell
674,875
-11,085
-2% -$86.4K 0.06% 273
2025
Q2
$6.32M Buy
+685,960
New +$7.02M 0.09% 203
2019
Q4
– Sell
-1,200
Closed -$19K – 720
2019
Q3
$19K Buy
+1,200
New +$19.7K ﹤0.01% 701

Other funds holding EOLS

Pinnacle Associates's EOLS Position: Q3 2026 in Review

Pinnacle Associates increased its Evolus (EOLS) stake by 5.6% in Q3 2026, buying an estimated $620K and bringing the position to 1,570,061 shares worth $12.6M. The position accounts for 0.14% of the portfolio, ranked #151.

Pinnacle Associates first reported a position in EOLS in Q3 2019 and has held it in 7 quarters since. 23 funds tracked by Wall St. Rank hold EOLS as of Q3 2026.

  • Pinnacle Associates held 1,570,061 shares of Evolus worth $12.6M as of Q3 2026.
  • Pinnacle Associates bought 82,797 Evolus shares in Q3 2026, an estimated $620K.
  • Evolus made up 0.14% of Pinnacle Associates's portfolio in Q3 2026, its #151 holding.
  • Pinnacle Associates first reported a position in Evolus in Q3 2019 and has held it in 7 quarters since.
  • 23 funds tracked by Wall St. Rank held Evolus as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.